Diagnostic Gene Biomarker Selection for Alzheimer’s Classification using Machine Learning
Karthik Sekaran1, Sudha. M2

1Karthik Sekaran*, School of Information Technology and Engineering, Vellore Institute of Technology, Vellore, India.
2Dr. M. Sudha, Associate Professor, School of Information Technology and Engineering, Vellore Institute of Technology, Vellore, India

Manuscript received on September 16, 2019. | Revised Manuscript received on 24 September, 2019. | Manuscript published on October 10, 2019. | PP: 2348-2352 | Volume-8 Issue-12, October 2019. | Retrieval Number: L33721081219/2019©BEIESP | DOI: 10.35940/ijitee.L3372.1081219
Open Access | Ethics and Policies | Cite | Mendeley | Indexing and Abstracting
© The Authors. Blue Eyes Intelligence Engineering and Sciences Publication (BEIESP). This is an open access article under the CC-BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Abstract: Disease (AD), also referred to as Alzheimer’s is a neurodegenerative disease and most common type of dementia. It starts at an older age and slowly progressive over time. It is a brain disease which causes loss of memory, reasoning and thinking capability of a person. Short-term memory loss is one of the main symptoms of the AD. Other common symptoms are said to be mood-swings, difficulty in understanding language and its interpretation etc. The major problem in the AD is, it can’t be reverted, but controllable with proper treatment. Genetic factors have a high impact on developing an AD, which can be inherited through genes. According to recent studies, gene therapy shows better results for Alzheimer’s patients than other common medications. It reduces the risk effect of the AD and has a gradual improvement on the patient’s condition. So, identification of gene biomarkers, having high involvement in developing AD could improve positive response over the treatment. In this paper, gene expressions of AD patients and normal peoples are analyzed using statistical approaches and Machine Learning (ML) algorithms. Differential Gene Expression (DEG) identification has an important part in the selection of most informative genes. Potential gene biomarkers are selected using a meta-heuristic global optimization algorithm called Rhinoceros Search Algorithm (RSA). As an outcome from RSA, 24 novel gene biomarkers are identified. Four supervised ML algorithms such as Support Vector Machines (SVM), Random Forest (RF), Naïve Bayes (NB) and Multilayered Perceptron Neural Network (MLP-NN) are used for the classification of two different group of samples. Among them, RSA-MLP-NN model achieved 100% accuracy on identifying the distinction between AD and normal genes and proved its efficacy.
Keywords: Alzheimer’s disease, Biomarkers, Gene Expression, Healthcare, Machine Learning
Scope of the Article: Machine Learning